Tharimmune Plunges 12.27% Amid Fed Policy Concerns, AI Sell-Off

On August 22, 2025, Tharimmune's stock experienced a significant drop of 12.27% in pre-market trading, reflecting investor concerns and market volatility.

Tharimmune's stock price has been influenced by broader market trends and economic policies. Concerns over Federal Reserve policy have led to a decline in US index futures, with the S&P 500 and Dow Jones Industrial Average both showing pre-market losses. These macroeconomic factors have contributed to the overall market sentiment, impacting Tharimmune's stock performance.

Additionally, the market has been grappling with sustainability concerns related to artificial intelligence, which has led to a tech sell-off. This broader market trend has also affected Tharimmune, as investors reassess the company's prospects in light of these developments.